Terumo Medical Corporation Executive and Leadership Team

Bob Quinn, the Chief Executive Officer at Terumo Medical Corporation, directs the overall strategic vision and operational execution for the organization. Quinn's leadership ensures alignment with Terumo Corporation's global objectives, driving growth and innovation in the medical product manufacturing sector. Overseeing all major business units, Quinn focuses on expanding market presence and enhancing product development pipelines. This executive role involves fostering a culture of excellence and accountability across all departments, ensuring the company's commitment to quality and patient well-being. Quinn's strategic initiatives are critical for navigating the competitive landscape and securing long-term financial stability. The Chief Executive Officer's purview encompasses all aspects of the company's operations, from research and development to market delivery, ensuring seamless integration of new technologies and therapies. Bob Quinn's guidance solidifies Terumo Medical Corporation's position as a leader in advanced medical solutions.

Shana Stewart, the Chief Executive Officer, Medical Device Trading Region at Terumo Medical Corporation, spearheads the strategic direction and commercial success within designated global trading territories. Stewart's leadership focuses on expanding market access and driving sales for Terumo's diverse portfolio of medical products, including endovascular therapy solutions and clinical thermometers. This executive role involves cultivating strong relationships with regional partners and stakeholders, ensuring efficient distribution and market penetration. Stewart oversees the commercial teams responsible for market analysis, sales strategy, and business development within the medical device trading sector. The Chief Executive Officer's objective is to maximize revenue and market share by adapting global strategies to local market dynamics. Shana Stewart's expertise in regional market operations is instrumental in achieving Terumo Medical Corporation's international growth targets.

John Pinto, the Chief Financial Officer at Terumo Medical Corporation, manages all financial operations and strategic financial planning. Pinto's responsibilities include overseeing budgeting, forecasting, financial reporting, and capital allocation to support the company's manufacturing and development of medical products. This role is crucial for maintaining the financial health of the organization, ensuring robust fiscal management for hollow-fiber technology, blood-management systems, and endovascular therapy solutions. Pinto works closely with other executive leaders to identify investment opportunities and mitigate financial risks, thereby safeguarding the company's assets and profitability. The Chief Financial Officer's expertise is vital in guiding the company's financial strategy, particularly in areas of expansion and technological advancement. John Pinto's diligent financial oversight enables Terumo Medical Corporation to pursue its mission of improving healthcare outcomes through innovative medical devices.

Kota Yamamura, the President at Terumo Medical Corporation, provides executive leadership and strategic oversight for key operational areas. Yamamura's role involves driving initiatives that enhance the company's manufacturing capabilities for medical products, including hollow-fiber technology and blood-management systems. This leadership position contributes to the overall strategic planning and execution of business objectives, ensuring operational excellence and product quality. Yamamura collaborates with other senior executives to foster innovation and maintain Terumo Medical Corporation's competitive edge in the healthcare industry. The President's focus is on optimizing internal processes and resource allocation to support the company's mission of improving patient care worldwide. Kota Yamamura's dedication to operational efficiency supports the sustained growth and development of Terumo Medical Corporation's product lines.

Keiichi Amatatsu, the President at Terumo Medical Corporation, directs strategic initiatives and operational frameworks critical to the company's success in the medical product sector. Amatatsu's leadership ensures the effective implementation of strategies related to the development and distribution of products such as clinical thermometers and endovascular therapy solutions. This executive position involves overseeing cross-functional teams to achieve key performance indicators and uphold the company's commitment to quality and innovation. Amatatsu works to enhance operational efficiencies and drive business growth by identifying new market opportunities and strengthening existing partnerships. The President's responsibilities include guiding the company's long-term vision and ensuring alignment with global healthcare standards. Keiichi Amatatsu's strategic guidance reinforces Terumo Medical Corporation's commitment to advancing medical technology and patient outcomes.

Kalyan Balsubramanian, the Chief Information Officer & Chief Information Officer, ) & Vice President, Information Technology at Terumo Medical Corporation, architects and executes the company's comprehensive information technology strategy. Balsubramanian oversees the development and implementation of robust IT infrastructure, ensuring the security, efficiency, and scalability of systems that support the manufacturing of medical products. This leadership position is vital for integrating advanced digital solutions across all operational facets, including hollow-fiber technology and blood-management systems. Balsubramanian drives technological innovation, enhancing data management, cybersecurity, and digital transformation initiatives to support Terumo Medical Corporation's global objectives. The Chief Information Officer's focus extends to optimizing IT resources and ensuring seamless technological integration for research, development, and production. Kalyan Balsubramanian's strategic IT leadership empowers the organization to leverage technology for improved operational performance and market competitiveness.

Michael Martinelli, the Senior VP, Medcal Affairs & Chief Medical Officer at Terumo Medical Corporation, leads the medical affairs strategy and provides critical clinical insights for product development and market positioning. Martinelli's expertise ensures that Terumo's medical products, including blood-management systems and endovascular therapy solutions, meet the highest clinical standards and address unmet patient needs. This role involves collaborating with research and development teams to guide innovation and validate the efficacy of new technologies. The Chief Medical Officer's purview extends to engaging with the medical community, fostering scientific exchange, and ensuring regulatory compliance. Martinelli's clinical leadership is essential for maintaining Terumo Medical Corporation's reputation for quality and advancing patient care through evidence-based medical solutions. Michael Martinelli's contributions are vital for aligning product innovation with clinical practice and patient well-being.